Off-label indications

Clinical trials for Off-label indications explained in plain language.

Never miss a new study

Get alerted when new Off-label indications trials appear

Sign up with your email to follow new studies for Off-label indications, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Last-Resort cancer therapy made available to patients with no other options

Disease control Expanded access

This program provides early access to CTL019, a cell therapy that reprograms a patient's own immune cells to attack cancer. It is for people with lymphoma or leukemia who have no other treatment choices and cannot join a clinical trial. The goal is to offer a potential benefit wh…

Matched conditions: OFF-LABEL INDICATIONS

Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Jun 27, 2026 12:23 UTC

Off-label indications

Get alerted when new Off-label indications trials appear

Last-Resort cancer therapy made available to patients with no other options